R(+)-8-OH-DPAT, a 5-HT(1A) receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex

Brain Research

Volumn 743, Issue 1-2, 1996, Pages 357-361

  Kuroki, Toshihide ^a,b   Ichikawa, Junji ^a   Dai, Jin ^a   Meltzer, Herbert Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

5 HT(1A) receptor; anxiety; D amphetamine; dopamine; microdialysis; prefrontal cortex; R(+) 8 OH DPAT; rat; serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AMPHETAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMPHETAMINE; ANIMALS; ANTI-ANXIETY AGENTS; DOPAMINE; DOPAMINE AGONISTS; DRUG EVALUATION, PRECLINICAL; MALE; MICRODIALYSIS; PIPERAZINES; PREFRONTAL CORTEX; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030462454     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01111-0     Document Type: Article

References (25)

1. Arborelius, L., Nomikos, G.G., Hacksell, U. and Svensson, T.H., (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex, Acta Physiol. Scand., 148 (1993) 465-466.
2. 1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover, Br. J. Pharmacol., 113 (1994) 425-430.
3. Barnes, N.M., Cheng, C.H.K., Costall, B., Ge, J. and Naylor, R.J., Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride, Br. J. Pharmacol., 107 (1992) 233-239.
4. Barrett, J.E. and Vanover, K., 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions, Psychopharmacology (Berl.), 112 (1993) 1-12.
5. 1 receptor agonists and p-chloroamphetamine, Synapse, 5 (1990) 120-133.
6. Chopin, P. and Briley, M., Animal model of anxiety: the effect of compounds that modify 5-HT neurotransmission, Trends Pharmacol. Sci., 8 (1987) 383-388.
7. 1A receptor agonists: recent developments and controversial issues, Psychopharmacology (Berl.), 121 (1995) 1-26.
8. File, S.E. and Hyde, J.R.G., A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilizers and of stimulants, Pharmacol. Biochem. Behav., 11 (1979) 65-69.
9. 1A receptor antagonist, Br. J. Pharmacol., 112 (1994) 91P.
10. Gardier, A.M., Trillat, A.-C., Malagié, I. and Jacquot, C., 8-OH-DPAT attenuates the dexfenfluramine-induced increase in extracellular serotonin: an in vivo dialysis study, Eur. J. Pharmacol., 265 (1994) 107-110.
11. Handley, S.L. and McBlane, J.W., 5HT drug in animal models of anxiety, Psychopharmacology (Berl.), 112 (1993) 13-20.
12. 1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens, Eur. J. Pharmacol., 287 (1995) 179-184.
13. Kalén, P., Strecker, R.E., Rosengren, E. and Björklund, A., Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection, J. Neurochem., 51 (1988) 1422-1435.
14. Lapin, I.P., Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol, Pharmacol. Biochem. Behav., 44 (1993) 241-243.
15. Pei, Q., Zetterström, T. and Fillenz, M., Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the rat, Neuroscience, 35 (1990) 133-138.
16. Pellow, S., Chopin, P., File, S.E. and Briley, M., Validation of the open: closed arm entries in an elevated plus maze: a novel test of anxiety in the rat, J. Neurosci. Methods, 14 (1985) 149-167.
17. Raiteri, M., Bertollini, A., Angelini, F. and Levi, G., D-Amphetamine as a releaser or uptake inhibitor of biogenic amines in synaptosomes, Eur. J. Pharmacol., 34 (1975) 189-195.
18. 1A agonist ±-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine, Synapse, 18 (1994) 218-224.
19. Rex, A., Marsden, C.A. and Fink, H., Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze, Psychopharmacology (Berl.), 110 (1993) 490-496.
20. 1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 17 (1993) 87-104.
21. 3H]8-OH-DPAT labeling of serotonin uptake sites, Brain Res., 617 (1993) 159-162.
22. Tanda, G., Carboni, E., Frau, R. and Di Chiara, G., Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl.), 15 (1994) 285-288.
23. 1A receptor-related anxiolytics, Trends Pharmacol. Sci., 8 (1987) 432-437.
24. Yoshioka, M., Matsumoto, M., Togashi, H. and Saito, H., Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex, Pharmacol. Biochem. Behav., 51 (1995) 515-519.
25. Zetterström, T., Sharp, T., Collin, A.K. and Ungerstedt, U., In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC, Eur. J. Pharmacol., 148 (1988) 327-334.